High risk of death following a hip fracture in patients with COPD

{"title":"High risk of death following a hip fracture in patients with COPD","authors":"","doi":"10.1016/j.rmedu.2008.02.007","DOIUrl":null,"url":null,"abstract":"<div><p>Introduction: Mortality rates after hip fracture have not declined in 20 years. We assessed the impact of chronic obstructive pulmonary disease (COPD) on mortality after hip fracture, and compared mortality in this cohort to persons without hip fracture in a population-based prospective cohort study.</p><p>Methods: Using Danish health care registries, we identified persons &gt;/=40 years old with first-time hospitalization for hip fracture between 1/1/1998 and 1/31/2003. Hospitalization for COPD was assessed from hospital discharge registries. Using Cox regression, we computed relative risks (RR) and 95% confidence intervals (CI) for mortality endpoints among persons with COPD compared to persons without COPD. Mortality following hip fracture was also compared to age and gender matched controls without hip fracture.</p><p>Results: We identified 11,985 persons with first-time hospitalization for hip fracture; 771 (6.4%) had a diagnosis of COPD. Average follow up was 22 months. Compared to persons without COPD, mortality following hip fracture in persons with COPD was RR=1.58 (95% CI 1.30–1.90) at 30 days, RR=1.52 (95% CI 1.30–1.77) at 90-days, RR=1.58 (95% CI 1.40–1.78) at 1 year, and RR=1.71 (95% CI 1.55–1.88) overall. The 1-year mortality in persons with hip fracture and COPD was approximately 3–5 times greater than in controls without hip fracture.</p><p>Conclusions: In this cohort, persons with COPD have a 60–70% higher risk of death following hip fracture than those without COPD. In addition, hip fracture and COPD increased 1-year mortality 3–5 times that of persons without hip fracture.</p><p>Reproduced with permission from Springer</p></div>","PeriodicalId":101083,"journal":{"name":"Respiratory Medicine: COPD Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmedu.2008.02.007","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine: COPD Update","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1745045408000154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Mortality rates after hip fracture have not declined in 20 years. We assessed the impact of chronic obstructive pulmonary disease (COPD) on mortality after hip fracture, and compared mortality in this cohort to persons without hip fracture in a population-based prospective cohort study.

Methods: Using Danish health care registries, we identified persons >/=40 years old with first-time hospitalization for hip fracture between 1/1/1998 and 1/31/2003. Hospitalization for COPD was assessed from hospital discharge registries. Using Cox regression, we computed relative risks (RR) and 95% confidence intervals (CI) for mortality endpoints among persons with COPD compared to persons without COPD. Mortality following hip fracture was also compared to age and gender matched controls without hip fracture.

Results: We identified 11,985 persons with first-time hospitalization for hip fracture; 771 (6.4%) had a diagnosis of COPD. Average follow up was 22 months. Compared to persons without COPD, mortality following hip fracture in persons with COPD was RR=1.58 (95% CI 1.30–1.90) at 30 days, RR=1.52 (95% CI 1.30–1.77) at 90-days, RR=1.58 (95% CI 1.40–1.78) at 1 year, and RR=1.71 (95% CI 1.55–1.88) overall. The 1-year mortality in persons with hip fracture and COPD was approximately 3–5 times greater than in controls without hip fracture.

Conclusions: In this cohort, persons with COPD have a 60–70% higher risk of death following hip fracture than those without COPD. In addition, hip fracture and COPD increased 1-year mortality 3–5 times that of persons without hip fracture.

Reproduced with permission from Springer

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
慢性阻塞性肺病患者髋部骨折后死亡的高风险
导言:髋部骨折后的死亡率20年来没有下降。我们评估了慢性阻塞性肺疾病(COPD)对髋部骨折后死亡率的影响,并在一项基于人群的前瞻性队列研究中比较了该队列与非髋部骨折患者的死亡率。方法:使用丹麦卫生保健登记,我们确定了1998年1月1日至2003年1月31日期间因髋部骨折首次住院的40岁患者。根据出院登记对COPD住院进行评估。使用Cox回归,我们计算了COPD患者与非COPD患者死亡率终点的相对危险度(RR)和95%置信区间(CI)。髋部骨折后的死亡率也与没有髋部骨折的年龄和性别匹配的对照组进行了比较。结果:我们确定了11985例首次因髋部骨折住院的患者;771例(6.4%)被诊断为COPD。平均随访时间为22个月。与非COPD患者相比,COPD患者髋部骨折后30天的死亡率RR=1.58 (95% CI 1.30-1.90), 90天的RR=1.52 (95% CI 1.30-1.77), 1年的RR=1.58 (95% CI 1.40-1.78),总体RR=1.71 (95% CI 1.55-1.88)。髋部骨折合并COPD患者的1年死亡率约为无髋部骨折对照组的3-5倍。结论:在该队列中,COPD患者髋部骨折后死亡风险比非COPD患者高60-70%。此外,髋部骨折和慢性阻塞性肺病患者1年死亡率是无髋部骨折患者的3-5倍。经Springer许可转载
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Editorial ATS 2009 Conference Report Diabetes and metabolic dysfunction in COPD Investigating a potential role for macrolide therapy in COPD Comparison of new prognostic assessments in COPD patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1